279 related articles for article (PubMed ID: 27661011)
1. Prevalence and clinical significance of nonorgan specific antibodies in patients with autoimmune thyroiditis as predictor markers for rheumatic diseases.
Elnady BM; Kamal NM; Shaker RHM; Soliman AF; Hasan WA; Alghamdi HA; Algethami MM; Jajah MB
Medicine (Baltimore); 2016 Sep; 95(38):e4336. PubMed ID: 27661011
[TBL] [Abstract][Full Text] [Related]
2. Rheumatic Disease Autoantibodies in Patients with Autoimmune Thyroid Diseases.
Nisihara R; Pigosso YG; Prado N; Utiyama SRR; De Carvalho GA; Skare TL
Med Princ Pract; 2018; 27(4):332-336. PubMed ID: 29864750
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
Yang Z; Ren Y; Liu D; Lin F; Liang Y
APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of positive autoimmune biomarkers in the brucellosis patients.
Ahmadinejad Z; Abdollahi A; Ziaee V; Domiraei Z; Najafizadeh SR; Jafari S; Ahmadinejad M
Clin Rheumatol; 2016 Oct; 35(10):2573-8. PubMed ID: 26781780
[TBL] [Abstract][Full Text] [Related]
5. Rheumatic disease among Oklahoma tribal populations: a cross-sectional study.
Gaddy JR; Vista ES; Robertson JM; Dedeke AB; Roberts VC; Klein WS; Levin JH; Mota FH; Cooper TM; Grim GA; Khan S; James JA
J Rheumatol; 2012 Oct; 39(10):1934-41. PubMed ID: 22896022
[TBL] [Abstract][Full Text] [Related]
6. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
Us D; Gülmez D; Hasçelik G
Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune thyroid disease and autoimmune rheumatic disorders: a two-sided analysis.
Lazúrová I; Benhatchi K; Rovenský J; Kozáková D; Wagnerová H; Tajtáková M; Shoenfeld Y; Macejova Z
Ann N Y Acad Sci; 2009 Sep; 1173():211-6. PubMed ID: 19758153
[TBL] [Abstract][Full Text] [Related]
8. The significance of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus.
Popescu C; Zofotă S; Bojincă V; Ionescu R
Rom J Intern Med; 2013; 51(3-4):179-87. PubMed ID: 24620631
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of autoantibodies to cyclic citrullinated peptide in patients with rheumatic diseases other than rheumatoid arthritis: a French multicenter study.
Fabien N; Olsson NO; Goetz J; Johanet C; Escande A; Bardin N; Sanmarco M; Andre C; Chevailler A; Humbel RL; Chretien P; Monier JC; Fortenfant F; Oksman F; Taillefer MF; Sibilia J
Clin Rev Allergy Immunol; 2008 Feb; 34(1):40-4. PubMed ID: 18247159
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of rheumatic manifestations and non-organ specific autoimmunity in patients with autoimmune thyreopathy].
Benhatchi K; Lazúrová I; Kozáková D; Rovenský J
Vnitr Lek; 2010 Feb; 56(2):106-10. PubMed ID: 20329579
[TBL] [Abstract][Full Text] [Related]
11. Mitral valve prolapse in autoimmune thyroid disease: an index of systemic autoimmunity?
Evangelopoulou ME; Alevizaki M; Toumanidis S; Piperingos G; Mavrikakis M; Sotou D; Evangelopoulou K; Koutras DA
Thyroid; 1999 Oct; 9(10):973-7. PubMed ID: 10560950
[TBL] [Abstract][Full Text] [Related]
12. Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis.
Bruns A; Nicaise-Roland P; Hayem G; Palazzo E; Dieudé P; Grootenboer-Mignot S; Chollet-Martin S; Meyer O
Joint Bone Spine; 2009 May; 76(3):248-53. PubMed ID: 19208451
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against cyclic citrullinated peptides in patients affected by rheumatoid arthritis before and after infliximab treatment.
Caramaschi P; Biasi D; Tonolli E; Pieropan S; Martinelli N; Carletto A; Volpe A; Bambara LM
Rheumatol Int; 2005 Nov; 26(1):58-62. PubMed ID: 15726373
[TBL] [Abstract][Full Text] [Related]
14. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL
J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508
[TBL] [Abstract][Full Text] [Related]
15. Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study.
Amezcua-Guerra LM; Springall R; Marquez-Velasco R; Gómez-García L; Vargas A; Bojalil R
Arthritis Res Ther; 2006; 8(5):R144. PubMed ID: 16934155
[TBL] [Abstract][Full Text] [Related]
16. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis.
Nell VP; Machold KP; Stamm TA; Eberl G; Heinzl H; Uffmann M; Smolen JS; Steiner G
Ann Rheum Dis; 2005 Dec; 64(12):1731-6. PubMed ID: 15878904
[TBL] [Abstract][Full Text] [Related]
17. Image analysis of fibrosis in labial salivary glands of patients with systemic autoimmune diseases. Close correlation of lobular fibrosis to seropositive rheumatoid arthritis and increased anti-CCP and RF titres in the serum.
Katona K; Farkas N; Kneif M; SütŐ G; Berki T; Balatonyi B; Tornóczky T
Pathology; 2018 Jun; 50(4):418-425. PubMed ID: 29735168
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
Agrawal S; Misra R; Aggarwal A
Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
[TBL] [Abstract][Full Text] [Related]
19. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases.
Tektonidou MG; Anapliotou M; Vlachoyiannopoulos P; Moutsopoulos HM
Ann Rheum Dis; 2004 Sep; 63(9):1159-61. PubMed ID: 15308528
[TBL] [Abstract][Full Text] [Related]
20. Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis.
Bas S; Genevay S; Meyer O; Gabay C
Rheumatology (Oxford); 2003 May; 42(5):677-80. PubMed ID: 12709545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
